Cargando…

CRISPR Technology: A Jewish Legal Perspective

Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human lon...

Descripción completa

Detalles Bibliográficos
Autores principales: Loike, John D., Flaum, Rabbi Tzvi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Rambam Health Care Campus 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622389/
https://www.ncbi.nlm.nih.gov/pubmed/36394501
http://dx.doi.org/10.5041/RMMJ.10487
_version_ 1784821756945498112
author Loike, John D.
Flaum, Rabbi Tzvi
author_facet Loike, John D.
Flaum, Rabbi Tzvi
author_sort Loike, John D.
collection PubMed
description Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future.
format Online
Article
Text
id pubmed-9622389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Rambam Health Care Campus
record_format MEDLINE/PubMed
spelling pubmed-96223892022-11-04 CRISPR Technology: A Jewish Legal Perspective Loike, John D. Flaum, Rabbi Tzvi Rambam Maimonides Med J Perspective Clustered regularly interspaced short palindromic repeats (CRISPR) gene editing is an innovative and potentially game-changing biotechnology that can potentially reverse DNA mutations in a tissue-specific manner. In addition, CRISPR is being targeted for xenotransplantation, for increasing human longevity, in animal breeding, and in plant science. However, there are many ethical challenges that emerge from CRISPR technology. This article discusses several positions that relate to these ethical challenges from a Jewish legal perspective. In addition, we present several other applications of CRISPR technology that lack a defined Jewish legal precedent and require rabbinical scholars to address and resolve them in the future. Rambam Health Care Campus 2022-10-27 /pmc/articles/PMC9622389/ /pubmed/36394501 http://dx.doi.org/10.5041/RMMJ.10487 Text en Copyright: © 2022 Loike and Flaum https://creativecommons.org/licenses/by/3.0/This is an open-access article. All its content, except where otherwise noted, is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0 (https://creativecommons.org/licenses/by/3.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Perspective
Loike, John D.
Flaum, Rabbi Tzvi
CRISPR Technology: A Jewish Legal Perspective
title CRISPR Technology: A Jewish Legal Perspective
title_full CRISPR Technology: A Jewish Legal Perspective
title_fullStr CRISPR Technology: A Jewish Legal Perspective
title_full_unstemmed CRISPR Technology: A Jewish Legal Perspective
title_short CRISPR Technology: A Jewish Legal Perspective
title_sort crispr technology: a jewish legal perspective
topic Perspective
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622389/
https://www.ncbi.nlm.nih.gov/pubmed/36394501
http://dx.doi.org/10.5041/RMMJ.10487
work_keys_str_mv AT loikejohnd crisprtechnologyajewishlegalperspective
AT flaumrabbitzvi crisprtechnologyajewishlegalperspective